NCT03968068

Brief Summary

The first week after a stroke is a particularly important time, as improving blood flow may limit secondary ischaemic damage to the brain and help reduce the overall burden neurological injury and future disability. Small studies in patients with stroke have shown that moderate aerobic exercise increases blood flow to the brain, however, no studies have evaluated the safety of aerobic exercise within the first week after stroke, nor whether it results in changes to cerebral blood flow. Remote ischaemic conditioning (RIC) is when ischaemia is induced to a limb for short periods of time by inflating pressure cuffs around arms or legs to above systolic pressures (mmHg). This procedure is performed for periods that avoid physical injury to the limbs, but induce neurohormonal, systemic or vascular changes in the body. These changes often result in improved blood supply to various areas of the body. The use of RIC in the acute period after stroke is currently being investigated in a number of large randomised controlled trials e.g. RECAST, RESIST, however, our understanding of how RIC actually works is incomplete. Importantly, there is scarce data on the acute effects of RIC on cerebral blood flow (CBF), a potentially pivotal mechanism behind its effects. We propose an exploratory study to evaluate whether it is feasible, acceptable and safe to undertake low and moderate intensity aerobic exercise or remote ischaemic conditioning (RIC) in patients during the acute period after stroke, and whether either of these interventions result in changes to cerebral blood flow velocity (CBFv) in the major cerebral arteries. We will compare any changes to those in a cohort of healthy volunteers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 28, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 30, 2019

Completed
8 days until next milestone

Study Start

First participant enrolled

June 7, 2019

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

January 3, 2024

Status Verified

January 1, 2024

Enrollment Period

2.6 years

First QC Date

May 28, 2019

Last Update Submit

January 2, 2024

Conditions

Outcome Measures

Primary Outcomes (6)

  • Number of Incidences of RICTreatment-Emergent Adverse Events.

    Safety of the RIC intervention will be assessed by measuring the Number of Adverse Events experienced by participants that are related to the RIC intervention.

    48 hours

  • Number of Incidences of Exercise Treatment-Emergent Adverse Events.

    Safety of the exercise intervention will be assessed by measuring the Number of Adverse Events experienced by participants that are related to the exercise intervention.

    48 hours

  • Number of participants reporting RIC associated discomfort on a likert scale

    Reported grade of discomfort associated with RIC will be measured on a likert scale of 0-5, 1 being very uncomfortable to 5 being very comfortable. Acceptance of RIC will be defined as an average score of \>3/5 on the likert scale.

    48 hours

  • Number of participants reporting exercise associated discomfort on a likert scale

    Reported grade of discomfort associated with exercise will be measured on a likert scale of 0-5, 1 being very uncomfortable to 5 being very comfortable. Acceptance of exercise will be defined as an average score of \>3/5 on the likert scale.

    48 hours

  • % of RIC intervention completed and recorded

    Feasibility of RIC will be defined as \>80% of the intervention being completed and recorded.

    48 hours

  • % of exercise intervention completed and recorded

    Feasibility of exercise will be defined as \>80% of the intervention being completed and recorded.

    48 hours

Secondary Outcomes (1)

  • Change from baseline in cerebral blood flow velocity.

    48 hours

Study Arms (2)

Exercise

EXPERIMENTAL
Procedure: Exercise Procedure

Remote Ischaemic Conditioning

EXPERIMENTAL
Procedure: Remote Ischaemic Conditioning

Interventions

Patients will undergo 30 minutes of light-moderate intensity leg cycling, using the Letto-2 (Motomed, UK) in the semi-supine position.

Exercise

Patients will undergo 4 cycles of upper limb RIC using a blood pressure cuff. Each cycle will involve inflating the blood pressure cuff to 200 mmHg for five minutes around the upper arm, followed by a period of relaxation of the cuff for a further 5 minutes. The total RIC treatment time will take 40 minutes.

Remote Ischaemic Conditioning

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult (age \> 18) patients who have suffered acute ischaemic stroke between 2-7 days previously, or healthy adult (\>18 years).
  • Ability to provide written informed consent
  • Ability to mobilise lower body limbs (at least one leg)
  • Ability to comply with study procedures in the opinion of the treating physician.

You may not qualify if:

  • Haemorrhagic Stroke
  • Ischaemic stroke \< 2 days or \>10 days
  • Disability preventing lower extremity cycling
  • New York Heart Failure Classification stage III/IV
  • History of ischaemic stroke
  • Current diagnosis of cancer
  • Resting Blood pressure \> 180 / 100 mmHg
  • Clinically unstable
  • History or presence of significant peripheral vascular disease in the upper limbs.
  • History or presence of complex neuropathic pains or peripheral neuropathy in the arms.
  • Presence of lymphoedema in the arms.
  • Presence of skin ulceration to the arms.
  • Uncontrolled arrhythmia, hypertension, diabetes or angina.
  • Acute deep vein thrombosis, pulmonary embolism or pulmonary infection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sheffield Teaching Hospitals NHS FT

Sheffield, United Kingdom

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Ali Ali, MD

    Sheffield Teaching Hospitals NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 28, 2019

First Posted

May 30, 2019

Study Start

June 7, 2019

Primary Completion

December 31, 2021

Study Completion

December 31, 2021

Last Updated

January 3, 2024

Record last verified: 2024-01

Locations